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Abstract
Background: The RasWGDP^RasWGTP cycle plays a central role
in eukaryotic signaling cascades. Mutations in Ras which stabilize
activated RasWGTP lead to a continuous stimulation of down-
stream effectors and ultimately to cell proliferation. Ras mutants
which increase the steady-state concentration of RasWGTP are
involved in about 30% of all human cancers. It is therefore of great
interest to develop a biosensor which is sensitive to RasWGTP but
not to RasWGDP.
Results : The Ras binding domain (RBD) of c-Raf1 was
synthesized from two unprotected peptide segments by native
chemical ligation. Two fluorescent amino acids with structures
based on the nitrobenz-2-oxa-1,3-diazole and coumaryl chromo-
phores were incorporated at a site which is close to the RBD/
RasWGTP binding surface. Additionally, a C-terminal tag consist-
ing of His6 was introduced. The Kd values for binding of the site-
specifically modified proteins to RasWGTP are comparable to that
of wild-type RBD. Immobilization of C-terminal His6 tag-
modified fluorescent RBD onto Ni-NTA-coated surfaces allowed
the detection of RasWGTP in the 100 nM range. Likewise,
RasWGTP/Q61L (an oncogenic mutant of Ras with very low
intrinsic GTP hydrolysis activity) can also be detected in this assay
system. RasWGDP does not bind to the immobilized RBD, thus
allowing discrimination between inactive and activated Ras.
Conclusions: The site-specific incorporation of a fluorescent
group at a strategic position in a Ras effector protein allows the
detection of activated Ras with high sensitivity. This example
illustrates the fact that the chemical synthesis of proteins or
protein domains makes it possible to incorporate any kind of
natural or unnatural amino acid at the position of choice, thereby
enabling the facile preparation of specific biosensors, enhanced
detection systems for drug screening, or the synthesis of activated
proteins, e.g. phosphorylated proteins involved in signaling
pathways, as defined molecular species. ß 2001 Elsevier Science
Ltd. All rights reserved.
Keywords: Chemical protein synthesis ; Fluorescent biosensor; Native
chemical ligation; Ras binding domain of c-Raf1; Site-speci¢c labeling
1. Introduction
In recent years, chemical synthesis by means of the na-
tive chemical ligation of unprotected peptides [1] has be-
come a viable method for the preparation of a wide vari-
ety of biologically active proteins [2]. These include
cytokines, enzymes (e.g. human secretory phospholipase
A2 [3]), and e¡ector molecules (e.g. the Ras binding do-
main (RBD) fragment of c-Raf1 [4]). Even integral mem-
brane proteins, a class of proteins which will become of
great signi¢cance in research in the near future, have been
prepared by total chemical synthesis [5]. Furthermore, the
expressed protein ligation technique [6] has enabled the
production of polypeptide thioesters by recombinant
means for use in native chemical ligation. The combina-
tion of chemically synthesized peptides with recombinant
polypeptides greatly increases the versatility and appli-
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cability of chemical protein synthesis. Since chemical syn-
thesis is inherently not limited to the use of the 20 genet-
ically encoded amino acids as building blocks, it is foresee-
able that tailor-made proteins with customized properties
suitable for research and for biotechnological applications
can be prepared conveniently [7]. Examples of such cus-
tom-tailored proteins have already appeared in the litera-
ture. For instance, Sydor et al. [4] introduced a £uores-
cently labeled Trp analog into the RBD of c-Raf1 to study
the kinetics of its binding to Ras, which belongs to the
superfamily of small GTPases. In another example, Cot-
ton and Muir [8] designed and assembled a dual-labeled
£uorescence biosensor for Crk-II phosphorylation.
One of the challenging tasks in biochemistry will be
concerned with the investigation and development of pro-
tein-based systems for use in the diagnosis of diseases and
for use in drug design and discovery. An important aspect
of these developments will be the speci¢c immobilization
of the monitoring protein on functionalized surfaces. The
immobilization of enzymes and other proteins for chip or
biosensor development has become increasingly important
in the light of genome sequencing projects. First e¡orts to
generate biosensors for in vivo measurements were devel-
oped in the early 1960s and led to glucose, lactate, urea,
and glutamate/glutamine biosensors. All these biosensors
employ enzymes (oxidoreductases) and provide their signal
in the form of electroactive species which are detected by
an electrode [9]. During the last decade, DNA chips have
provided an e⁄cient method for the detection of muta-
tions in speci¢c genes as diagnostic markers of particular
diseases and for the detection of di¡erences in gene ex-
pression levels [10]. In contrast, the design of protein-
based biochips and their applications is still in its infancy
[11,12].
An important system for the development of a biosen-
sor is the Ras^Raf protein pair. The small GTPase Ras
plays a major role in cell signaling events and cell prolif-
eration. The interaction between RasWGTP and its down-
stream e¡ector c-Raf1 is of crucial importance for the
regulation of cell division and di¡erentiation [13]. Ras
acts as a molecular switch which in its GTP-bound, but
not in its GDP-bound state activates downstream signal-
ing events. Certain mutations in Ras, such as G12V or
Q61L, lead to an increase in the steady-state concentra-
tion of RasWGTP due to lower hydrolysis activity, poten-
tially leading to uncontrolled cell proliferation. Mutants
with accelerated GDP dissociation rates can lead to sim-
ilar e¡ects. Ras mutants are involved in about 30% of all
human cancers [14,15]. Therefore, it is of general interest,
e.g. in cancer diagnostics, to establish a biosensor for
the reliable determination of RasWGTP in the presence of
RasWGDP.
One of the most promising approaches to the develop-
ment of biosensors involves the use of unnatural amino
acids with tailored properties at speci¢c sites in proteins of
interest. It has been shown that a sequence of 81 amino
acids from the N-terminal region of c-Raf1 (RBD) is suf-
¢cient for tight binding to Ras [16]. This interaction has
been extensively investigated using kinetic and structural
methods [17^19] as well as chemically synthesized RBD
containing £uorescent Trp or the unnatural Trp analog
N1-methyl-7-azatryptophan at position 91. The latter ex-
ample provided evidence that small £uorescent amino
acids are suitable monitors for the binding event without
perturbing the kinetics of this process [4]. However, the
properties of those £uorescent residues were not appropri-
ate for the development of a biosensor, because the £uo-
rescent residues that were used displayed only low extinc-
tion coe⁄cients and poor quantum yields. Furthermore,
environmental e¡ects had only a small in£uence on the
emission intensity and/or the emission maximum of the
£uorophores. Therefore, new small amino acids with fa-
vorable £uorescence properties had to be selected and in-
corporated into RBD.
In the present work, the synthesis of a sensor which can
detect the potentially oncogenic RasWGTP in the presence
of RasWGDP is described. To demonstrate the potential
applicability of surface-immobilized proteins, we have
chemically synthesized the RBD of c-Raf1 containing a
suitable £uorescent amino acid in close proximity to the
Ras binding site, and immobilized this detector protein on
a derivatized surface. The properties of this protein bio-
sensor for Ras and Ras mutants are described.
2. Results
2.1. Synthesis of £uorescent RBD
In earlier work it was shown that Trp or the Trp analog
N1-methyl-7-azatryptophan could be introduced by chem-
ical protein synthesis into RBD in position 91 (see Fig. 1B)
without loss of activity [4]. However, the results also
showed that the poor sensitivity of the £uorescent chro-
mophores would not allow the development of a biosen-
sor. Therefore, two £uorescent amino acids based on the
chromophores 7-nitrobenz-2-oxa-1,3-diazole (NBD) and
6,7-dimethoxy-coumaryl (DMCA) (Fig. 1A), which prom-
ised favorable properties (red-shifted emission maxima,
higher extinction coe⁄cients and quantum yields), were
chosen for the incorporation into RBD. The red-shifted
emission maxima of the £uorescent probes do not interfere
with the Trp emission which permits the selective detection
of binding events even in the presence of an excess of Trp
residues. The NBD-containing amino acid has the addi-
tional advantage that its £uorescence is quite sensitive to
the local environment.
Each amino acid was incorporated into RBD at posi-
tion 91, replacing a leucine, using the strategy of native
chemical ligation [1] and following the procedure de-
scribed in [4] (see also Fig. 1B). The N-terminal segments,
which contained the £uorescent amino acids, were synthe-
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sized on a resin designed to generate a thioester at the
C-terminus after HF cleavage. The C-terminal segments
were synthesized on a standard ^OCH2-phenylacetamido-
methyl resin. An additional C-terminal six-residue histi-
dine tag was added to allow immobilization on Ni-NTA
surfaces [20,21]. All polypeptides were puri¢ed by reversed
phase HPLC and identi¢ed by electrospray mass spec-
trometry. Chemical ligation of the unprotected peptide
segments to yield the full-length RBD polypeptide was
carried out as previously published [4]. The ligated poly-
peptides were obtained at a purity of s 98% with recov-
ered yields of 20^40% based on the N-terminal peptide
segments.
After reconstitution of the lyophilized polypeptides in
aqueous bu¡er, correct folding of the synthesized proteins
was checked by circular dichroism (CD) spectroscopy
(data not shown). All spectra are in good agreement
with those of native RBD [4,22,23]. A comparison of
CD data obtained from measurements of RBD/
L91NBD-DAP/His with or without 5% hexa£uoroisopro-
panol (HFIPA) showed only an increase of the absorption
mainly at 225 nm in the presence of HFIPA whereas the
negative ellipticity at 205 nm, indicative of K-helical struc-
tures, remained una¡ected.
2.2. Fluorescence measurements
The £uorescence emission spectra of RBD labeled with
DMCA and NBD-DAP are shown in Fig. 2. The maxima
are at 425 nm and 538 nm, respectively, and are almost
identical to those determined for the corresponding amino
acids. The binding of RasWGppNHp to these proteins re-
sults in a decrease of the £uorescence intensity which is of
the order of 10% for the DMCA £uorophore and 20% for
the NBD-DAP £uorophore. On the other hand, in the
presence of RasWGDP, the inactive state of Ras, the £uo-
rescence intensities do not change, indicating that
RasWGDP, as expected, does not bind to RBD (data not
shown).
The £uorescence properties of NBD- and DMCA-RBD
can be modi¢ed by addition of small amounts of organic
solvents. Addition of aprotic polar solvents such as di-
methylsulfoxide or dimethylformamide leads to a general
decrease of the £uorescence intensity (data not shown).
However, HFIPA induces a considerable change in the
£uorescence behavior which is most notable for RBD/
L91NBD-DAP. 5% HFIPA induces not only a decrease
of the £uorescence intensity, but also shifts the emission
maximum from 538 nm to 528 nm. On binding of
RasWGppNHp, the £uorescence intensity then increases
nearly 100% without altering the position of the band
(Fig. 2C). Thus, use of this solvent potentially increases
the sensitivity of the assay. Indeed, titrating RBD/
L91NBD-DAP in the presence and absence of
RasWGppNHp with HFIPA shows clearly that the largest
increase of £uorescence intensity after addition of
RasWGppNHp occurs in the range of 5^7.5% HFIPA
(data not shown). At concentrations larger than 10% HFI-
PA, the change in £uorescence intensity is considerably
reduced.
Fig. 1. (A) Structure of the incorporated amino acids: (1) N-Boc-L-(6,7-dimethoxy-4-coumaryl)-alanine and (2) N2-Boc-N3-(7-nitrobenz-2-oxa-1,3-diazol-
4-yl)-L-2,3-diaminopropionic acid. (B) Sequence of the RBD. Secondary structure elements are indicated by white and gray bars above the sequence.
The labeling site at position 91 and the ligation site between Cys 95 and Cys 96 are indicated by arrows.
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2.3. Stopped-£ow experiments
The binding process of RBD to RasWGppNHp, which
occurs in the subsecond time range, can be followed by
stopped-£ow techniques. The kinetic parameters derived
from these experiments are compiled in Table 1. For a
detailed description of the kinetic analysis used here, see
Sydor et al. [19]. Calculation of the Kd values from the
association and dissociation rate constants shows that
wild-type RBD displays a dissociation constant of 170
Fig. 2. (A) Fluorescence emission of RBD/L91DMCA in the presence of RasWGppNHp (red) and without RasWGppNHp (black). Excitation at 350 nm.
(B) Fluorescence of RBD/L91NBD-DAP in the presence of RasWGppNHp (red) and without RasWGppNHp (black). Excitation at 465 nm. (C) Fluores-
cence emission of RBD/L91NBD-DAP after addition of 5% HFIPA to the bu¡er, in the presence of RasWGppNHp (red) and without RasWGppNHp
(green). The black line shows the £uorescence emission of RBD/L91NBD-DAP without HFIPA and without RasWGppNHp.
Table 1
Kinetic parameters for the interaction of chemically synthesized (ch) RBD proteins with RasWGppNHp at 25‡C
reaction kdiss (s31) kass (M31s31) Kd (nM)
1. wt RBD (ch)+RasWmGppNHp 5.9 3.5U107 170
2. RBD/L91NBD (ch)+RasWGppNHp 11 1.8U107 610
3. RBD/His (ch)+RasWmGppNHp 5.9 1.2U107 490
4. RBD/L91NBD/His (ch)+RasWGppNHp 14 2.7U107 520
5. RBD/L91DMCA (ch)+Ras/Y32WWGppNHp 10 2.1U107 480
Reactions 1 and 3: kinetics monitored using mant £uorescence of RasWmGppNHp. Reactions 2, 4 and 5: kinetics monitored using £uorescence of labels
or FRET.
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nM towards activated Ras. The introduction of a His tag
or the modi¢cation at position 91 by the £uorescent ana-
logs increases this value to about 500 nM. A comparison
of the kass and kdiss data indicates that the lowered binding
a⁄nity is due to a combination of a decrease in kass and an
increase in kdiss.
It should be noted that energy transfer between
mantGppNHp at the active site of Ras and NBD-DAP-
containing RBD occurs if the sample is excited at 366 nm.
The emission can then be monitored above 530 nm. This
observation provides another method of detecting the spe-
ci¢c interaction between RasWmantGppNHp and RBD/
L91NBD-DAP in situations in which both proteins carry
a label, for example in screening for inhibitors of the in-
teraction.
In the case of RBD/L91DMCA, the emission above 398
nm (excitation 334 nm) did not provide an adequate signal
for stopped-£ow measurements. Therefore, a Trp mutant
of Ras (Ras/Y32W) was used for £uorescence resonance
energy transfer (FRET) experiments in which Trp was the
donor to DMCA as an acceptor. In this way it was pos-
sible to determine the Kd value for the interaction of Ras/
Y32WWGppNHp and RBD/L91DMCA (see Table 1).
In preliminary experiments (data not shown), it was also
shown that £uorescence lifetime measurements can also be
used to monitor the RBD^Ras interaction. Although there
was no change in the lifetime of the DMCA label on
interaction with Ras (5.8 ns), the £uorescence lifetime of
the NBD label decreases from 4.6 to 2.8 ns on complex
formation.
2.4. Immobilization experiments
The RBDs containing the £uorescent probes DMCA
and NBD-DAP and a His6 tag at the C-terminus were
immobilized on opalescent microtiter plates from Qiagen
with Ni-NTA-coated wells (see schematic representation in
Fig. 3). The binding capacity of the plates is approxi-
mately 10 pmol/well for globular 25 kDa proteins. To
prevent unspeci¢c binding of proteins to the polymer sur-
face, the wells were pre-incubated with a bu¡er containing
5% fat-free milk powder. Subsequently, RBD/L91NBD-
DAP/His was added at various concentrations (from 100
nM to 2 WM protein). After overnight incubation, the
wells were extensively washed with bu¡er B and bu¡er B
containing Tween 20 (0.05%), and the £uorescence inten-
sity on the surface was measured. Since unspeci¢c binding
of non-His-tagged protein was still quite high, an addi-
tional washing step with 50 mM imidazole was included.
RBD/L91NBD-DAP/His £uorescence was excited at 485
nm and the emission was monitored at 538 nm in a Fluo-
roskan device. Due to the lack of availability of suitable
Fig. 3. Immobilization of RBD/L91NBD-DAP via the C-terminal His tag on a Ni-NTA-coated surface. RasWGppNHp interacts with the immobilized
RBD at its binding interface consisting of two L-sheets (modelled from the Rap1a:RBD structure [9a]). The £uorescence label is shown close to this
binding interface between RBD and Ras.
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¢lter pairs for this apparatus, similar experiments were not
performed with DMCA-labeled RBD.
The results are shown in Fig. 4. The binding of RBD/
L91NBD-DAP/His6 tag can be detected easily from the
£uorescence signal (lane 1, second column). Unspeci¢c
binding is quite low, as can be seen from the data obtained
from immobilized RBD lacking the His tag (lane 1, ¢rst
column). Adding RasWGppNHp to the well with bound
His-tagged RBD decreases the £uorescence by about
20% (lane 1, third column), a value comparable to that
measured in solution. The concentration of RasWGppNHp
was varied between 150 nM and 2 WM. The £uorescence
intensity changes about 20% at concentrations above 500
nM RasWGppNHp. Decreasing the amount of activated
Ras to 300 nM reduced the £uorescence di¡erence to
about 8%. This is in harmony with the measured Kd value
for the interaction.
As was expected from the solution experiments (Fig.
2C) the addition of 5% HFIPA decreased the £uorescence
yield of the surface-bound RBD signi¢cantly. Addition of
activated Ras then resulted in a ca. 30% increase in £uo-
rescence (Fig. 4, lane 3). The interaction was detectable
down to ca. 500 nM RasWGppNHp. Under the present
experimental conditions, reliable data are not obtained
at lower concentrations.
Preliminary measurements performed in the presence of
Fig. 4. (A) Data of £uorescence measurements on surface with RasWGppNHp (lanes 1 and 3) or RasWGDP (lanes 2 and 4; shown in black) and without
these proteins (shown in gray) in the presence of HFIPA and without. All measurements were done with a ¢lter pair of 485 nm (excitation) and 538
nm (emission) and were performed at least 10 times. (B) Di¡erences of £uorescence intensities in the presence of Ras/Q61LWGTP or GDP without and
with 5% HFIPA.
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complete HeLa cell extracts still demonstrated a signi¢cant
change in £uorescence intensities in the absence as well as
in the presence of 5% HFIPA. Although in these experi-
ments the background £uorescence was increased, the de-
tection level of RasWGppNHp was not negatively in£u-
enced.
Addition of RasWGDP at concentrations of 0.5^5 WM to
the RBD-containing wells did not result in a change of
£uorescence intensity, regardless of the addition of HFIPA
(Fig. 4, lanes 2 and 4).
It was of interest that binding of oncogenic mutants of
Ras to RBD/L91NBD-DAP/His also resulted in a detect-
able signal. This is the case, as demonstrated in Fig. 4B
in which the £uorescence di¡erences between bound-
and unbound Ras/Q61L are plotted. Again, the GDP-
bound form does not induce any £uorescence change. It
should be noted that in these experiments, Ras/Q61LWGTP
could be used directly, since the GTP hydrolysis rate of
this mutant is 65 times slower than that of wild-type Ras
[14].
3. Discussion
The results presented here show that chemical synthesis
of £uorescently labeled RBD protein combined with its
immobilization on a commercially available microtiter
plate can lead to a bio-surface which can be used to detect
the oncogene product Ras in its activated form. The sys-
tem reported here is not yet fully optimized in terms of
sensitivity, but it seems likely that signi¢cant improve-
ments can be made. Some of these are discussed below.
For the purposes of the present application (i.e. detec-
tion of unlabeled Ras in its active form), a suitable £uo-
rescent probe should be small in size so that it can be
incorporated as close to the protein backbone as possible
without disturbing protein^protein interactions. The pho-
tochemical properties of the £uorescent amino acids
should permit the sensitive detection of protein structural
changes caused by the binding event, and in a system such
as the present one in which large structural changes do not
occur on binding, this means that the label must be placed
close to, but not in, the binding interface. In other words,
a compromise has to be made between a position which
still detects the bound protein partner but which does not
perturb its KD. The results obtained show that this has, in
principle, been achieved, but it is quite possible that posi-
tions in the sequence can be found which undergo more
profound changes of environment without interfering with
the interaction. In addition to these requirements, for
some applications which could be envisaged, the photo-
chemical stability of the chromophore should also be
high enough to allow the high excitation intensities neces-
sary for single molecule detection experiments.
The £uorescent unnatural amino acids (L-DMCA and L-
NBD-DAP) which were chosen for the present work ful¢l
some of these requirements. L-NBD-DAP, which has al-
ready been used in in vivo translation experiments [26,27],
and L-DMCA are both comparable in size to Trp, and
were chosen for this reason. Their £uorescence maxima,
at 538 nm and 425 nm, are well separated from that of Trp
at ca. 340 nm. Quantum yields and extinction coe⁄cients
are also much more appropriate than those of tryptophan
derivatives, and in the case of the NBD label, the excita-
tion wavelength (ca. 480 nm) is in a range where standard
lasers can be used. On the other hand, the photochemical
stability is not satisfactory for methods which require
high excitation intensities. Although the binding of
RasWGppNHp to RBD/L91NBD in single molecule experi-
ments could be detected, the chromophore was bleached
very rapidly (A. Koltermann, personal communication).
An extension of the present work to include dyes known
to be suitable for single molecule detection would certainly
be feasible.
A further property of interest of the £uorescent labels
used is their potential for FRET measurements. We have
used them as acceptors in the present work (resonance
energy acceptors in the following pairings: Trp/DMCA
and mGppNHp/NBD-DAP). Both combinations led to
adequate FRET signals in the stopped-£ow experiments
described. The labels used could also be used as donors
if suitable acceptors were introduced into Ras. Since
powerful methods have recently been introduced for site-
speci¢c labeling of GTPases of the Ras superfamily [28],
an acceptor molecule could be introduced into the C-ter-
minal region of Ras. This would be an attractive possibil-
ity for the NBD-labeled protein, since its excitation wave-
length is suitable for currently available lasers and the
emission wavelength is appropriate for transfer to several
commonly used dyes.
The results reported on the interaction of the £uores-
cently labeled RBD molecules with Ras show that the
a⁄nity is una¡ected (see Table 1) by the modi¢cation
and is still in the 500 nM range. The £uorescence change
(quenching) seen on interaction of Ras with labeled RBD
is relatively modest, but this situation is improved by the
inclusion of 5% HFIPA as cosolvent. This solvent de-
creases the £uorescence of free (or surface-bound) RBD/
L91NBD-DAP, but there is a large increase in £uores-
cence on interaction with Ras, presumably due to ‘shelter-
ing’ of that region of the RBD molecule from the cosol-
vent by the bound Ras. Using immobilized RBD/
L91NBD-DAP/His, the lower limit for reliable detection
of activated Ras was ca. 300 nM. This is partly the result
of a combination of a not particularly high a⁄nity and a
less than optimal signal change on binding Ras. It is likely
that this can be improved signi¢cantly. The ¢lter combi-
nation, which was limited by the apparatus used, was not
optimal, since the emission ¢lter wavelength was too long
to take most advantage of the changes induced on bind-
ing. The loss of a⁄nity in the protein construct used ap-
pears to be mainly due to the C-terminal His tag, as can
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be seen from the data in Table 1. Although the C-terminus
is quite far away from the binding site (see Fig. 3) it still
appears to interfere somewhat with the binding process. It
might therefore be of interest to choose another site, e.g.
in the loop region amino acids 113^118.
Compared to ELISA methods using antibodies to iden-
tify proteins, the approach described here has the general
advantage that the speci¢c detection of RasWGTP in the
presence of RasWGDP becomes possible. This di¡erentia-
tion cannot be achieved using antibody-based techniques,
due to the small conformational di¡erences between the
GDP and the GTP states of Ras, and to the metastable
nature of the individual states.
Chemical synthesis of proteins provides the necessary
tools to incorporate speci¢cally designed amino acids at
speci¢c sites of the protein molecule [2], so that a suitable
compatible chemistry for the immobilization can be se-
lected. Increasing the capacity of the immobilizing surface
is not likely to have a major in£uence, since the fraction of
immobilized RBD molecules occupied by Ras will still be
the same as with a lower capacity at a given Ras concen-
tration. However, more £uorescent indicator on the sur-
face means more overall emission intensity, which might
improve the signal to noise ratio.
4. Signi¢cance
The work described here has provided evidence that the
chemical synthesis of proteins and their immobilization on
surfaces is a viable tool for the design of biosensors. As an
example, the biologically and medically important Ras/
RBD system was chosen and it could be shown that the
binding of RasWGTP to RBD could be observed with high
sensitivity even in the presence of RasWGDP. Oncogenic
mutants with impaired hydrolysis activity for GTP could
also be detected, demonstrating the potential of the system
in cancer diagnostics and in screening of RasWGTP inhib-
itors and/or substances which increase the GTP hydrolysis
rate in oncogenic Ras mutants. Native chemical ligation,
in combination with expressed protein ligation methods
for making recombinant polypeptide thioesters [6,28],
will enable the approach described here to be applied to
even larger proteins including enzymes, receptors, and
even membrane proteins [5]. The combination of site-spe-
ci¢c chemical incorporation of £uorescent amino acids
into the target protein with site-directed immobilization
of the modi¢ed protein onto specialized surfaces such as
Si, SiO2, or Au constitutes a general approach for the
development of biosensors and screening systems for
drugs, inhibitors, and other protein ligands.
5. Materials and methods
tert-Butyloxycarbonyl (Boc)-protected amino acids were pur-
chased from Peptides International. 2-(1H-Benzotriazol-1-yl)-
1,1,3,3-tetramethyl-uronium hexa£uorophosphate was obtained
from Spectrum (Gardena, CA, USA). The Boc-amino acyl-
OCH2-phenylacetamidomethyl resins and N,N-diisopropylethyl-
amine were bought from Applied Biosystems. Tri£uoroacetic
acid was from Halocarbon (Hackensack, NJ, USA). Hydrogen
£uoride was purchased from Matheson. NK-Boc-L-DAP was
bought from Bachem. All other chemicals were obtained from
Fluka in the highest purity available.
5.1. Synthesis of N-Boc-L-DMCA (1)
The £uorophore was synthesized according to Bennett et al.
[24,25]. The K-amino group was protected with the Boc group
with 1.1 equivalent Boc-ON in water/dioxane (1:1) and 1.5 equiv-
alents of triethylamine. The enantiomeric purity was checked by
HPLC using Teicoplanin as the chiral stationary phase [29,30].
The enantiomeric purity was better than 98%.
5.2. Synthesis of N2-Boc-N3-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)-L-
2,3-DAP (2)
4-Chloro-7-nitrobenz-2-oxa-1,3-diazole was coupled with N2-
Boc-L-2,3-DAP in ethanol/water 1:1 in the presence of 1.2 equiv-
alents of triethylamine for 6 h at room temperature. The resulting
mixture was puri¢ed by £ash silica gel chromatography using
dichloromethane/methanol 9:1.
5.3. Peptide synthesis
Solid phase peptide synthesis was performed manually or on a
custom-modi¢ed 430A peptide synthesizer from Applied Biosys-
tems, using Boc chemistry, in situ neutralization, and 2-(1H-ben-
zotriazol-1-yl)-1,1,3,3-tetramethyl-uronium hexa£uorophosphate
activation protocols [31,32]. Unnatural £uorescent amino acids
were coupled manually using the above mentioned neutralization
and activation protocol. All N-terminal peptide segments were
synthesized on a resin that generates a C-terminal thioester after
HF cleavage [33]. The peptides were deprotected and cleaved
from the resin using anhydrous HF, precipitated with ether, dis-
solved in aqueous acetonitrile, and lyophilized. Peptides segments
were puri¢ed by reversed phase HPLC after HF cleavage with a
C4 column from Vydac (Hesperia, CA, USA) using linear gra-
dients of bu¡er B (acetonitrile with 0.08% tri£uoroacetic acid) in
bu¡er A (water with 0.1% tri£uoroacetic acid) and UV detection
at 214 nm. Samples were analyzed by electrospray mass spec-
trometry with a Perkin-Elmer Sciex API-I quadrupole mass spec-
trometer.
5.4. Native chemical ligation
Ligation of the peptide segments in 6 M guanidinium hydro-
chloride, 300 mM phosphate at pH 7, and 1% thiophenol over-
night produced the full-length polypeptide chain [1,34]. Puri¢ca-
tion and analysis were carried out as described above for the
peptide segments.
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5.5. Protein folding
The puri¢ed polypeptide chain was folded by dissolving 1 mg
protein in 1 ml of bu¡er (100 mM NaCl, 50 mM Tris^HCl, 5 mM
MgCl2, 5 mM dithiothreitol (DTT), pH 7.4). The solution was
gently stirred overnight at 4‡C and after this the solution was
shock frozen in liquid nitrogen and stored at 380‡C. For CD
spectroscopic measurements, the samples were dialyzed against
20 mM phosphate bu¡er at pH 7.4. CD spectra were recorded
on a Jasco J-710 spectropolarimeter at 25‡C in a quartz cell
with 0.2 cm pathlength and a ¢nal protein concentration of
60 WM.
5.6. Fluorescence spectroscopy
All £uorescence spectra were measured on an Aminco-Bowman
Series 2 luminescence spectrophotometer at 25‡C. The proteins
were dissolved in 100 mM NaCl, 50 mM Tris^HCl, 5 mM
MgCl2, 5 mM DTT at pH 7.4 at a concentration of 2 WM.
5.7. Fluorescence lifetime measurements
Frequency-domain £uorescence lifetimes of the proteins were
measured with an ISS K2 Multifrequence Phase £uorometer us-
ing a saturated solution of POPOP in ethanol as a reference.
RBD/L91NBD-DAP was excited at 460 nm and RBD/
L91DMCA at 350 nm. The emitted light was monitored through
¢lters with a cut-o¡ wavelength of 400 nm for RBD/L91DMCA
and without any ¢lter for RBD/L91NBD-DAP.
5.8. Stopped-£ow measurements
Stopped-£ow measurements of the Ras^RBD interaction were
carried out as described by Sydor et al. [19]. Excitation wave-
lengths were 334 nm for RBD/L91DMCA excitation, 436 nm
for RBD/L91NBD-DAP excitation and 289 nm for Trp excita-
tion in FRET experiments. Emitted light was monitored through
¢lters with cut-o¡ wavelengths of 398, 530, and 398 nm, respec-
tively.
5.9. Preparation of H-Ras proteins
Wild-type and mutant H-Ras proteins were prepared from Es-
cherichia coli using the ptac expression system as described [35].
The conversion into nucleotide-free H-Ras and nucleotide ex-
change against GppNHp or GTP was performed according to
[36].
5.10. Preparation of HeLa cell extract
HeLa cells were grown in Dulbecco’s Eagle’s medium supple-
mented with 10% fetal calf serum and 1% penicillin/streptomycin
solution. The cells were washed with a bu¡er containing 100 mM
NaCl, 50 mM Tris^HCl, 5 mM MgCl2 at pH 7.4 and lysed by
ultrasonication. After lysis a mixture of EDTA-free protease in-
hibitors was added.
5.11. Immobilization of RBDs
Ni-NTA HisSorb Plates from Qiagen were incubated overnight
with a bu¡er containing 150 mM NaCl, 50 mM KPi pH 7.4, and
5% fat-free milk powder (bu¡er A). The plates were washed with
150 mM NaCl, 50 mM KPi, 5 mM MgCl2, 5 mM DTT, pH 7.4
(bu¡er B) and incubated with di¡erent concentrations of £uores-
cent and non-£uorescent RBDs for 12 h. The plates were sub-
sequently washed with bu¡er B containing 0.05% Tween 20 and
with pure bu¡er B.
5.12. Fluorescence measurements on HisSorb plates
The £uorescence of immobilized RBDs was measured with a
Fluorskan Ascent FL from Labsystems using a ¢lter pair with
485 nm as excitation wavelength and 538 nm as emission wave-
length.
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